Loading clinical trials...
Loading clinical trials...
Phase II, Single-arm Study of Vistusertib (AZD2014) Monotherapy in Relapsed Small Cell Lung Cancer Patients Harboring RICTOR Amplification(SUKSE-D)
Conditions
Interventions
vistusertib (AZD2014)
Locations
1
South Korea
Samsung Medical center
Seoul, South Korea
Start Date
August 2, 2017
Primary Completion Date
May 3, 2018
Completion Date
June 29, 2018
Last Updated
September 20, 2018
NCT07190248
NCT06066138
NCT05692635
NCT07485114
NCT06305754
NCT04253964
Lead Sponsor
Samsung Medical Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions